C

Cytokinetics
D

CYTK

49.090
USD
1.44
(3.02%)
Market Closed
Volume
54,124
EPS
-5
Div Yield
-
P/E
-9
Market Cap
5,793,319,042
Related Instruments
    F
    FATE
    -0.04500
    (-2.17%)
    2.02500 USD
    G
    GH
    -1.065
    (-3.53%)
    29.130 USD
    S
    SRPT
    -4.470
    (-4.10%)
    104.600 USD
    V
    VKTX
    -3.960
    (-7.39%)
    49.620 USD
    X
    XLRN
    0
    (0%)
    0.000000 USD
    More
News

Title: Cytokinetics

Sector: Healthcare
Industry: Biotechnology
Cytokinetics Inc is a biotechnology company that develops muscle biology-driven treatments for diseases characterized by reduced muscle function, muscle weakness, and fatigue. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.